St. Jude Medical has received FDA clearance for its Epiducer neurostimulation lead delivery system for pain management, according to a company news release.
The Epiducer system allows placement of as many as three neurostimulation leads through a single entry point.
The system also allows introduction of St. Jude Medical S-Series paddle leads through a percutaneous entry.
Read the St. Jude Medical release on approval of Epiducer.
Related Articles on Neurostimulation Therapy:
5 Keys for Pain Management Physicians to Ensure Success in 2011
Neurostimulation System Shows Positive Findings in Treating Cluster Headache
Study: Peripheral Nerve Stimulation Reduces Migraines